Miromatrix Medical Inc. Common Stock
MIRO
MIRO was delisted on the 12th of December, 2023.
31 hedge funds and large institutions have $11.1M invested in Miromatrix Medical Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 3 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
11% more funds holding
Funds holding: 28 → 31 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less capital invested
Capital invested by funds: $11.2M → $11.1M (-$103K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$4.42M |
| 2 |
GS
Gagnon Securities
New York
|
+$1.53M |
| 3 |
GA
Gagnon Advisors
New York
|
+$850K |
| 4 |
RI
RTW Investments
New York
|
+$429K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$393K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIPM
G2 Investment Partners Management
New York
|
-$488K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$59K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$20.1K |
| 4 |
JP Morgan Chase
New York
|
-$5K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$96 |
MIRO Hedge Fund Activity: Q1 2023 in Review
31 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Miromatrix Medical Inc. Common Stock (MIRO) for Q1 2023, worth a combined $11.1M — down 0.92% from $11.2M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new MIRO positions and 3 closed out — a net gain of 3 holders — while 7 added to existing stakes and 2 trimmed.
The largest buyer was First Light Asset Management, adding an estimated $4.42M. The largest seller was G2 Investment Partners Management, cutting an estimated $488K.
- 31 institutional investors held Miromatrix Medical Inc. Common Stock (MIRO) as of Q1 2023, up from 28 in Q4 2022.
- Funds reported $11.1M of Miromatrix Medical Inc. Common Stock stock for Q1 2023, down 0.92% quarter-over-quarter.
- 6 funds opened new Miromatrix Medical Inc. Common Stock positions in Q1 2023 and 3 closed out, a net change of +3 holders.
- The largest Miromatrix Medical Inc. Common Stock buyer in Q1 2023 was First Light Asset Management, an estimated $4.42M added.
- The largest Miromatrix Medical Inc. Common Stock seller in Q1 2023 was G2 Investment Partners Management, an estimated $488K sold.
Based on aggregated 13F filings for Q1 2023.